COCRYSTAL PHARMA INC's ticker is COCP and the CUSIP is 19188J300. A total of 42 filers reported holding COCRYSTAL PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $948,000 | -29.0% | 3,255,081 | -0.0% | 0.00% | – |
| Q2 2022 | $1,335,000 | -25.8% | 3,255,085 | -0.5% | 0.00% | – |
| Q1 2022 | $1,800,000 | -15.7% | 3,272,638 | -0.3% | 0.00% | – |
| Q4 2021 | $2,134,000 | -38.2% | 3,283,201 | -0.1% | 0.00% | – |
| Q3 2021 | $3,451,000 | -11.0% | 3,287,000 | +5.9% | 0.00% | – |
| Q2 2021 | $3,878,000 | +42.5% | 3,103,035 | +58.5% | 0.00% | – |
| Q1 2021 | $2,722,000 | +2.3% | 1,957,773 | 0.0% | 0.00% | – |
| Q4 2020 | $2,662,000 | +127.9% | 1,957,773 | +55.9% | 0.00% | – |
| Q3 2020 | $1,168,000 | -8.5% | 1,256,049 | +49.7% | 0.00% | – |
| Q2 2020 | $1,276,000 | +108.8% | 839,252 | -2.4% | 0.00% | – |
| Q1 2020 | $611,000 | +241.3% | 860,240 | +139.1% | 0.00% | – |
| Q4 2019 | $179,000 | -75.6% | 359,760 | 0.0% | 0.00% | – |
| Q3 2019 | $734,000 | -13.3% | 359,760 | -0.2% | 0.00% | – |
| Q2 2019 | $847,000 | -10.1% | 360,364 | +4.4% | 0.00% | – |
| Q1 2019 | $942,000 | -8.9% | 345,028 | +20.2% | 0.00% | – |
| Q4 2018 | $1,034,000 | +175.0% | 287,149 | +91.0% | 0.00% | – |
| Q3 2018 | $376,000 | +401.3% | 150,371 | +630.0% | 0.00% | – |
| Q2 2018 | $75,000 | – | 20,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|